Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
OCTAVE Open: Tofacitinib Long-Term Extension in Ulcerative Colitis
NCT01470612Phase 3Completed
- Sponsor
- Pfizer
- Start
- Oct 2012
- Primary completion
- Aug 2020
- Modality
- Small Molecules
- Countries
- 31
01
Overview
A Phase 3 trial of tofacitinib in ulcerative colitis (UC), sponsored by Pfizer. Started Oct 2012; status: completed.
02
Drugs
03
Conditions
ulcerative colitis (UC)
Beyond the preview
Go deeper on NCT01470612.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01470612.